CO6501191A2 - Medio de cultivo celular para expresión de la proteina adamts - Google Patents
Medio de cultivo celular para expresión de la proteina adamtsInfo
- Publication number
- CO6501191A2 CO6501191A2 CO12033821A CO12033821A CO6501191A2 CO 6501191 A2 CO6501191 A2 CO 6501191A2 CO 12033821 A CO12033821 A CO 12033821A CO 12033821 A CO12033821 A CO 12033821A CO 6501191 A2 CO6501191 A2 CO 6501191A2
- Authority
- CO
- Colombia
- Prior art keywords
- expression
- adamts
- adamts protein
- cellular media
- methods
- Prior art date
Links
- 102000029750 ADAMTS Human genes 0.000 title abstract 5
- 108091022879 ADAMTS Proteins 0.000 title abstract 5
- 230000001413 cellular effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 102000043853 ADAMTS13 Human genes 0.000 abstract 2
- 108091005670 ADAMTS13 Proteins 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24087—ADAMTS13 endopeptidase (3.4.24.87)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/22—Zinc; Zn chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/99—Serum-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23047709P | 2009-07-31 | 2009-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6501191A2 true CO6501191A2 (es) | 2012-08-15 |
Family
ID=42668009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO12033821A CO6501191A2 (es) | 2009-07-31 | 2012-02-27 | Medio de cultivo celular para expresión de la proteina adamts |
Country Status (21)
| Country | Link |
|---|---|
| US (7) | US8313926B2 (OSRAM) |
| EP (1) | EP2459702B1 (OSRAM) |
| JP (5) | JP5451884B2 (OSRAM) |
| KR (5) | KR101808496B1 (OSRAM) |
| CN (2) | CN102549145B (OSRAM) |
| AU (1) | AU2010278751B2 (OSRAM) |
| BR (2) | BR112012002151B1 (OSRAM) |
| CA (1) | CA2769361A1 (OSRAM) |
| CO (1) | CO6501191A2 (OSRAM) |
| EA (1) | EA023193B1 (OSRAM) |
| ES (1) | ES2583258T3 (OSRAM) |
| HR (1) | HRP20160783T1 (OSRAM) |
| HU (1) | HUE029110T2 (OSRAM) |
| IN (1) | IN2012DN00801A (OSRAM) |
| MX (2) | MX2012001261A (OSRAM) |
| NZ (1) | NZ597727A (OSRAM) |
| PL (1) | PL2459702T3 (OSRAM) |
| PT (1) | PT2459702T (OSRAM) |
| SG (1) | SG178194A1 (OSRAM) |
| SI (1) | SI2459702T1 (OSRAM) |
| WO (1) | WO2011014838A1 (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101808496B1 (ko) * | 2009-07-31 | 2017-12-12 | 백스터 인터내셔널 인코포레이티드 | Adamts 단백질 발현을 위한 세포 배양 배지 |
| PT3064508T (pt) | 2010-07-08 | 2019-12-05 | Baxalta Inc | Método de produção de fvw recombinante de elevado peso molecular na cultura de células |
| WO2013006479A2 (en) | 2011-07-01 | 2013-01-10 | Amgen Inc. | Mammalian cell culture |
| WO2014062535A1 (en) | 2012-10-15 | 2014-04-24 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
| US9611455B2 (en) | 2013-03-13 | 2017-04-04 | Merck Sharp & Dohme Corp. | Adapted lepidopteran insect cells for the production of recombinant proteins |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| AU2014336555B2 (en) * | 2013-10-14 | 2020-12-03 | Ares Trading S.A | New medium for high performance mammalian fed-batch cultures |
| IL319240A (en) | 2014-06-04 | 2025-04-01 | Amgen Inc | Methods for collecting mammalian cell cultures |
| KR101867134B1 (ko) * | 2015-03-23 | 2018-06-12 | 한양대학교 산학협력단 | 포유류 세포를 이용하여 목적 물질을 고효율로 생산하기 위한 세포 배양 배지, 이를 이용한 세포 배양 방법 및 목적 물질의 생산 방법 |
| PL3298138T3 (pl) * | 2015-05-22 | 2022-12-05 | Dupont Nutrition Biosciences Aps | Dekarboksylaza acetomleczanowa |
| TWI797060B (zh) | 2015-08-04 | 2023-04-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
| CN116159130B (zh) | 2016-08-04 | 2025-09-09 | 武田药品工业株式会社 | 使用adamts13治疗、改善和/或预防镰状细胞病、急性肺损伤和/或急性呼吸窘迫综合征中的血管阻塞危象 |
| CA3040288A1 (en) * | 2016-11-04 | 2018-07-12 | Baxalta Incorporated | Adeno-associated virus purification methods |
| TW202526028A (zh) * | 2017-07-06 | 2025-07-01 | 美商雷傑納榮製藥公司 | 供製備糖蛋白之細胞培養方法 |
| TW202513790A (zh) * | 2018-03-16 | 2025-04-01 | 美商健臻公司 | 改善生產生物反應器中細胞存活力之方法 |
| CA3103443A1 (en) * | 2018-06-18 | 2019-12-26 | Synthetic Biologics, Inc. | Methods of making alkaline phosphatase agents |
| EP4037704B1 (en) | 2019-10-04 | 2025-12-03 | The Children's Medical Center Corporation | Adamts13 treatment to enhance graft survival |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| TW202128745A (zh) | 2019-12-06 | 2021-08-01 | 美商再生元醫藥公司 | 抗ｖｅｇｆ蛋白組合物及其製備方法 |
| US20230203469A1 (en) | 2020-04-02 | 2023-06-29 | Takeda Pharmaceutical Company Limited | Adamts13 variant, compositions, and uses thereof |
| MX2022013812A (es) | 2020-05-08 | 2022-12-15 | Regeneron Pharma | Trampas y mini-trampas de vegf y metodos para el tratamiento de trastornos oculares y cancer. |
| EP4153215A1 (en) | 2020-05-22 | 2023-03-29 | Takeda Pharmaceutical Company Limited | Adamts13 compositions and methods for treating and diagnosing complications of coronavirus disease |
| US20230020297A1 (en) * | 2020-06-05 | 2023-01-19 | Proabtech Co., Ltd. | Uox-albumin conjugate with certain numbers of albumin conjugated thereto, and manufacturing method thereof |
| CN111808822B (zh) * | 2020-07-02 | 2024-01-12 | 北京百普赛斯生物科技股份有限公司 | 细胞培养用补料液及提高重组hek293细胞蛋白表达量的方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5250421A (en) | 1986-01-03 | 1993-10-05 | Genetics Institute, Inc. | Method for producing factor VIII:C-type proteins |
| CZ280901B6 (cs) | 1988-10-06 | 1996-05-15 | Hideaki Yamada | Způsob kultivace bakterií |
| JPH0753104B2 (ja) * | 1989-02-28 | 1995-06-07 | 秀明 山田 | 細菌の培養法 |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| EP1213030B1 (en) | 1994-11-10 | 2009-04-22 | Baxter Healthcare SA | Method for producing biologicals in protein-free culture |
| AU703484B2 (en) | 1995-02-23 | 1999-03-25 | Quest International Services B.V. | Peptides for tissue and cell culture media |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| AU4330597A (en) | 1996-08-30 | 1998-03-19 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
| IT1285158B1 (it) | 1996-09-17 | 1998-06-03 | Angeletti P Ist Richerche Bio | Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il |
| WO1998015514A1 (en) | 1996-10-07 | 1998-04-16 | Solutia Inc. | Process for the hydroxylation of benzene |
| EP1983044B1 (en) | 1996-10-10 | 2016-08-10 | Life Technologies Corporation | Animal cell culture media comprising plant-derived nutrients |
| US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
| AT407255B (de) | 1997-06-20 | 2001-02-26 | Immuno Ag | Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons |
| US6475725B1 (en) | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| US6406909B1 (en) | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| US6926894B2 (en) | 2000-11-22 | 2005-08-09 | Baxter Aktiengesellschaft | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
| JP4723862B2 (ja) | 2002-12-23 | 2011-07-13 | フジフィルム マニュファクチャリング ユーロプ ビー．ブイ． | 細胞培養支持体を被覆する方法 |
| JP2007534675A (ja) * | 2004-04-16 | 2007-11-29 | ワイス | Ａｄａｍｔｓ−８タンパク質およびその使用 |
| US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| JP2007174948A (ja) * | 2005-12-27 | 2007-07-12 | Noritsu Koki Co Ltd | 酵素水製造装置 |
| JP4880997B2 (ja) * | 2005-12-28 | 2012-02-22 | アルフレッサファーマ株式会社 | Ａｄａｍｔｓ１３の安定化方法 |
| WO2007077217A2 (en) * | 2006-01-04 | 2007-07-12 | Baxter International Inc. | Oligopeptide-free cell culture media |
| CN101611268B (zh) * | 2006-12-22 | 2013-06-12 | 斯普灵格开利有限公司 | 用于空调单元的新鲜空气控制杆 |
| US20090067805A1 (en) | 2007-09-10 | 2009-03-12 | Victor Company Of Japan, Limited | Recording and reproducing device |
| HRP20171375T1 (hr) * | 2007-12-27 | 2017-12-15 | Baxalta GmbH | Postupci s kulturama stanica |
| KR101808496B1 (ko) * | 2009-07-31 | 2017-12-12 | 백스터 인터내셔널 인코포레이티드 | Adamts 단백질 발현을 위한 세포 배양 배지 |
-
2010
- 2010-07-30 KR KR1020177018298A patent/KR101808496B1/ko active Active
- 2010-07-30 AU AU2010278751A patent/AU2010278751B2/en active Active
- 2010-07-30 KR KR1020157033595A patent/KR101756354B1/ko active Active
- 2010-07-30 BR BR112012002151-6A patent/BR112012002151B1/pt active IP Right Grant
- 2010-07-30 BR BR122021005965-9A patent/BR122021005965B1/pt active IP Right Grant
- 2010-07-30 SG SG2012006839A patent/SG178194A1/en unknown
- 2010-07-30 SI SI201031238A patent/SI2459702T1/sl unknown
- 2010-07-30 EP EP10740810.6A patent/EP2459702B1/en active Active
- 2010-07-30 NZ NZ597727A patent/NZ597727A/xx unknown
- 2010-07-30 IN IN801DEN2012 patent/IN2012DN00801A/en unknown
- 2010-07-30 CA CA2769361A patent/CA2769361A1/en not_active Abandoned
- 2010-07-30 HR HRP20160783TT patent/HRP20160783T1/hr unknown
- 2010-07-30 PL PL10740810.6T patent/PL2459702T3/pl unknown
- 2010-07-30 PT PT107408106T patent/PT2459702T/pt unknown
- 2010-07-30 KR KR1020157009715A patent/KR101574056B1/ko active Active
- 2010-07-30 US US12/847,999 patent/US8313926B2/en active Active
- 2010-07-30 CN CN201080042028.1A patent/CN102549145B/zh active Active
- 2010-07-30 HU HUE10740810A patent/HUE029110T2/en unknown
- 2010-07-30 KR KR1020177035177A patent/KR101912552B1/ko active Active
- 2010-07-30 KR KR1020127005425A patent/KR101573972B1/ko active Active
- 2010-07-30 JP JP2012523110A patent/JP5451884B2/ja active Active
- 2010-07-30 WO PCT/US2010/044020 patent/WO2011014838A1/en not_active Ceased
- 2010-07-30 EA EA201270224A patent/EA023193B1/ru not_active IP Right Cessation
- 2010-07-30 CN CN201510186244.8A patent/CN104962539B/zh active Active
- 2010-07-30 MX MX2012001261A patent/MX2012001261A/es active IP Right Grant
- 2010-07-30 ES ES10740810.6T patent/ES2583258T3/es active Active
-
2012
- 2012-01-27 MX MX2013009470A patent/MX344970B/es unknown
- 2012-02-27 CO CO12033821A patent/CO6501191A2/es unknown
- 2012-09-19 US US13/622,939 patent/US8759026B2/en active Active
-
2014
- 2014-05-13 US US14/276,819 patent/US9127265B2/en active Active
-
2015
- 2015-07-23 US US14/807,745 patent/US9441216B2/en active Active
-
2016
- 2016-05-06 JP JP2016093240A patent/JP6511007B2/ja active Active
- 2016-08-09 US US15/232,626 patent/US10072254B2/en active Active
-
2018
- 2018-01-26 JP JP2018011373A patent/JP6567707B2/ja active Active
- 2018-09-08 US US16/125,688 patent/US10724024B2/en active Active
-
2019
- 2019-07-31 JP JP2019141485A patent/JP6883071B2/ja active Active
-
2020
- 2020-06-16 US US16/903,185 patent/US11254921B2/en active Active
-
2021
- 2021-05-07 JP JP2021079239A patent/JP7083059B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6501191A2 (es) | Medio de cultivo celular para expresión de la proteina adamts | |
| BR112013002811A8 (pt) | meios básicos simplificados para cultura celular pluripotente de humano | |
| CO6680636A2 (es) | Método para producir adamts13 recombinante en cultivo celular | |
| CR20140422A (es) | Composiciones de enzima digestiva estable | |
| BRPI0917993A2 (pt) | composições de célula-tronco mesenquimal purificada e métodos de purificação de composições de célula-tronco mesenquimal purificda. | |
| CR20120158A (es) | Compuestos de diòxido de iminotiadiazina como inhibidores de bace, composiciones y su uso. | |
| GT201200153A (es) | Derivados del ácido carbamoil-metil-amino-acético sustituido como inhibidores de nep novedosos | |
| DK201200196A (en) | Imaging and evaulating embryos, oocytes, and stem cells | |
| MX379016B (es) | Composiciones y metodos para tratar enfermedad de gaucher. | |
| CR11827A (es) | Activadores de glucoquinasa | |
| MX2010000944A (es) | Vectores baculovirales que comprenden secuencias de codificacion repetida con deformaciones diferenciales en codones. | |
| HN2006011218A (es) | Composiciones de tigeciclina y métodos de preparación | |
| GT200600264A (es) | Modificaciones cristalinas de piraclostrobina | |
| MX383346B (es) | Composiciones y metodos que comprenden variantes de serina proteasa. | |
| CO6612194A2 (es) | Métodos de purificaciñon de adamts 13 y otras proteinas recombinantes y sus composiciones | |
| EA201170638A1 (ru) | Способ получения аденовирусных векторов | |
| WO2010129294A3 (en) | Small molecules supporting pluripotent cell growth and methods thereof | |
| EA200701656A1 (ru) | Противообледенительная и/или антиобледенительная композиция и способ уменьшения температуры застывания сложных эфиров растительных масел (варианты) | |
| GT201400303A (es) | Purificación de iduronato-2- sulfatasa | |
| MX2010000348A (es) | Cultivo de celulas madre pluripotentes individuales. | |
| DE602007007666D1 (de) | Verfahren zur herstellung von nebivolol | |
| PA8676401A1 (es) | Metodos para purificar tigeciclina | |
| DE602006016735D1 (de) | Verfahren zur proliferation von stammzellen | |
| MX361428B (es) | Formas polimorficas st-246 y metodos de preparacion. | |
| CR20160307A (es) | Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas |